192 related articles for article (PubMed ID: 24497188)
41. Interventions for the treatment of borderline ovarian tumours.
Faluyi O; Mackean M; Gourley C; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD007696. PubMed ID: 20824864
[TBL] [Abstract][Full Text] [Related]
42. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Rosa DD; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT
Cochrane Database Syst Rev; 2012 Jun; 6(6):CD005342. PubMed ID: 22696349
[TBL] [Abstract][Full Text] [Related]
44. Surgical interventions for high grade vulval intraepithelial neoplasia.
Kaushik S; Pepas L; Nordin A; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2011 Jan; (1):CD007928. PubMed ID: 21249698
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy for metastatic and recurrent cervical cancer.
Scatchard K; Forrest JL; Flubacher M; Cornes P; Williams C
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006469. PubMed ID: 23076924
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Rosa DD; Medeiros LR; Edelweiss MI; Bozzetti MC; Pohlmann PR; Stein AT; Dickinson HO
Cochrane Database Syst Rev; 2009 Jul; (3):CD005342. PubMed ID: 19588370
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
Galaal K; Godfrey K; Naik R; Kucukmetin A; Bryant A
Cochrane Database Syst Rev; 2011 Jan; (1):CD006812. PubMed ID: 21249682
[TBL] [Abstract][Full Text] [Related]
48. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.
Donati OF; Lakhman Y; Sala E; Burger IA; Vargas HA; Goldman DA; Andikyan V; Park KJ; Chi DS; Hricak H
Eur Radiol; 2013 Oct; 23(10):2906-15. PubMed ID: 23652852
[TBL] [Abstract][Full Text] [Related]
49. Health education interventions to promote early presentation and referral for women with symptoms of endometrial cancer.
Cheewakriangkrai C; Kietpeerakool C; Charoenkwan K; Pattanittum P; John D; Aue-Aungkul A; Lumbiganon P
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013253. PubMed ID: 32168393
[TBL] [Abstract][Full Text] [Related]
50. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
51. Trends and current aspects of reconstructive surgery for gynecological cancers.
Loverro M; Aloisi A; Tortorella L; Aletti GD; Kumar A
Int J Gynecol Cancer; 2024 Mar; 34(3):426-435. PubMed ID: 38438169
[TBL] [Abstract][Full Text] [Related]
52. The impact of nutritional risk factors and sarcopenia on survival in patients treated with pelvic exenteration for recurrent gynaecological malignancy: a retrospective cohort study.
Seebacher V; Rockall A; Nobbenhuis M; Sohaib SA; Knogler T; Alvarez RM; Kolomainen D; Shepherd JH; Shaw C; Barton DP
Arch Gynecol Obstet; 2022 May; 305(5):1343-1352. PubMed ID: 34734326
[TBL] [Abstract][Full Text] [Related]
53. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.
Feuer DJ; Broadley KE
Cochrane Database Syst Rev; 2000; 2000(2):CD001219. PubMed ID: 10796761
[TBL] [Abstract][Full Text] [Related]
54. Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Lopez-Graniel C; Dolores R; Cetina L; Gonzalez A; Cantu D; Chanona J; Uribe J; Candelaria M; Brom R; de la Garza J; Duenas-Gonzalez A
BMC Cancer; 2005 Sep; 5():118. PubMed ID: 16171526
[TBL] [Abstract][Full Text] [Related]
55. Interventions for psychosexual dysfunction in women treated for gynaecological malignancy.
Flynn P; Kew F; Kisely SR
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD004708. PubMed ID: 19370605
[TBL] [Abstract][Full Text] [Related]
56. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival.
Park JY; Choi HJ; Jeong SY; Chung J; Park JK; Park SY
J Surg Oncol; 2007 Dec; 96(7):560-8. PubMed ID: 17708548
[TBL] [Abstract][Full Text] [Related]
57. The changing role for extended resections in an era of advanced radiotherapy techniques and novel therapies in gynaecological malignancy.
McBain RD; McGauran MFG; Tran KH; Au-Yeung G; Khaw PYL; McNally OM
Eur J Surg Oncol; 2022 Nov; 48(11):2308-2314. PubMed ID: 36184421
[TBL] [Abstract][Full Text] [Related]
58. Opportunities and Limitations of Pelvic Exenteration Surgery.
Lampe B; Luengas-Würzinger V; Weitz J; Roth S; Rawert F; Schuler E; Classen-von Spee S; Fix N; Baransi S; Dizdar A; Mallmann P; Schaser KD; Bogner A
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944783
[TBL] [Abstract][Full Text] [Related]
59. A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients.
Esmailzadeh A; Fakhari MS; Saedi N; Shokouhi N; Almasi-Hashiani A
BMC Cancer; 2024 May; 24(1):593. PubMed ID: 38750417
[TBL] [Abstract][Full Text] [Related]
60. Considerations for multimodal prehabilitation in women with gynaecological cancers: a scoping review using realist principles.
Saggu RK; Barlow P; Butler J; Ghaem-Maghami S; Hughes C; Lagergren P; McGregor AH; Shaw C; Wells M
BMC Womens Health; 2022 Jul; 22(1):300. PubMed ID: 35854346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
